Search Results 281-290 of 14822 for albumin

1. Health Topics - Mayo Clinic News Network

   Bats play an important role in many ecosystems around the world. They are a major predator of night-flying insects, including pests that cost farmers ...

2. Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   Serum albumin < 2.5 g/dL; Serum creatinine > 1.5× ULN (or a calculated creatinine clearance < 60 mL/min/1.73 m2). Patients with a significant cardiovascular ...

3. Metastatic Melanoma Clinical Trials - Mayo Clinic Research

   Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by ...

4. Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   dipstick, significant proteinuria [>300 mcg albumin/mg creatinine]), other significant renal disease, renal cancer, transplanted kidney, single kidney ...

5. Alisertib in Treating Young Patients with Recurrent or Refractory Solid Tumors or Leukemia - Mayo Clinic

   Serum albumin ≥ 2 g/dL; All patients and/or their parents or legal guardians must sign a written informed consent. Exclusion Criteria: Patients who are ...

6. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

   Platelet count ≥ 100,000/mm^3 (obtained ≤ 15 days prior to registration). Albumin ≥ 2.5 mg/dL (obtained ≤ 15 days prior to registration); Total bilirubin ...

7. A Study to Test Adding Pembrolizumab to Olaparib Alone as Therapy for Patients with Pancreatic Cancer That Has Spread with Inherited BRCA Mutations - Mayo Clinic

   Albumin ≥ 3.0 (within 14 days of registration);; Hemoglobin ≥ 9.0 g/dL. Patients must have CA19-9 obtained within 42 days prior to registration. Patients ...

8. A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) - Mayo Clinic

   Serum albumin ≥ 25 g/L (2.5 g/dL); For patients not receiving therapeutic anticoagulation: INR or aPTT ≤ 1.5 x ULN. For patients receiving therapeutic ...

9. Alpha-1-antitrypsin deficiency - Symptoms and causes - Mayo Clinic

   Learn about the symptoms and risk factors of alpha-1-antitrypsin deficiency, a condition passed down in families, that can affect the lungs, liver or both.

10. A Study To Confirm the Effectiveness and Safety of Terlipressin in Adults with Hepatorenal Syndrome Type 1 - Mayo Clinic

    ... albumin. Exclusion Criteria: Serum creatinine level greater than 7.0 mg/dL. At least 1 event of large volume paracentesis (LVP) at least 4 L within 2 days ...